Maybe you asked about hormone therapy and watched your doctor’s face do that careful little thing. The pause. The “well, there are risks.” The suggestion to try a fan, some layers, maybe a supplement from the vitamin aisle. And you went home and Googled until midnight, more confused than when you walked in.
Or maybe you never asked at all, because somewhere along the way you absorbed the message that hormones were dangerous and suffering was the responsible choice.
Here’s the news. On October 15, 2026, the doctors who treat women for a living published a new set of rules for menopause care. And the rules are on your side.
Key takeaways:
– ACOG strongly recommends systemic hormone therapy for hot flushes and related sleep problems in women without contraindications.
– ACOG says benefits outweigh risks for most women aged 50–59 or within 10 years of menopause with bothersome symptoms.
– SSRIs/SNRIs and neurokinin receptor antagonists are strongly recommended for women who can’t or don’t want hormones.
– Phytoestrogens and herbal supplements are not supported by the evidence.
– Between 50% and 92% of women in menopause report hot flushes or night sweats.
What happened
The American College of Obstetricians and Gynecologists, ACOG, is the professional organization for the OB-GYNs most women see. When ACOG publishes a clinical practice guideline, it’s telling its members, in writing, what good care looks like.
Its new guideline, Clinical Practice Guideline No. 13, covers the three things that knock so many of us flat: hot flushes and night sweats, sleep, and mood. It replaces guidance from January 2014. That’s more than a decade in which the official playbook didn’t change while women kept getting the pause, the fan, and the vitamin aisle.
(Yes, “hot flush.” ACOG now prefers it to “hot flash,” because the heat isn’t a momentary flash. It typically lasts one to five minutes. Anyone who has stood in a meeting quietly combusting already knew that.)
The big one: hormone therapy is back on the table
For more than two decades, women were told hormone therapy was too risky to consider. Here is what ACOG wrote now:
“ACOG recommends the use of systemic MHT” (menopausal hormone therapy) for hot flushes and night sweats, and for the sleep problems they cause, in women without medical reasons to avoid it. That’s a strong recommendation, the highest grade the guideline gives.
Then it goes further. In ACOG’s own words: “In general, the benefits of systemic MHT outweigh the risks for most patients with bothersome VMS and vasomotor-related sleep disturbance who are aged 50–59 years or within 10 years of menopause onset and have no contraindications to hormone therapy use.”
Read that twice. Benefits outweigh risks. For most women. From the people who write the standard of care.
That’s not a wellness influencer. That’s not a supplement company. That’s your doctor’s own professional body.
Why the old fear didn’t fit you
So where did all the fear come from? Mostly from the Women’s Health Initiative, the huge study that made headlines in the early 2000s and made hormone therapy sound like a loaded gun.
Here’s the part that rarely made the headlines. The new guideline points out that nearly 67% of the Women’s Health Initiative participants were 60 or older. That makes the findings difficult to apply to women in their 40s and 50s who are just entering the transition, which is exactly when most of us are looking for help.
That’s not a small footnote. That’s twenty-plus years of women in their late 40s being judged by risks measured in women in their 60s and 70s.
Timing matters. ACOG recommends that when hormone therapy is chosen, it’s started before age 60 or within 10 years of the start of natural menopause. After that window, the decision is more individual, and the risks look different.
Not a hormone person? You have real options too
Some women can’t take hormones. About 9% of US women have a genuine medical reason to avoid them. Others simply don’t want to. The guideline doesn’t leave either group out in the cold.
ACOG gives a strong recommendation to two non-hormonal options for women who don’t want or can’t take hormone therapy:
• SSRIs or SNRIs, a family of medications that can ease hot flushes and also treat depression.
• Neurokinin receptor antagonists, the newer non-hormonal drugs (brand names Veozah and Lynkuet) designed to quiet the brain’s overactive temperature signal. Both need liver monitoring, so ask about that.
It also suggests, as a lighter-grade recommendation, cognitive behavioral therapy for hot flushes, sleep and mood, plus mindfulness, exercise, clinical hypnosis and acupuncture. (CBT has real evidence behind it for menopause symptoms. Now your OB-GYN’s rulebook says so too.)
What the guideline says doesn’t work
This is the part the vitamin aisle won’t love.
In ACOG’s words, “The available evidence does not support the efficacy or safety of phytoestrogens (eg, soy isoflavones) or herbal supplements” for hot flushes or other menopausal symptoms. These products aren’t regulated by the FDA, and they haven’t been tested for safety, effectiveness, or purity the way medications are.
So if you’ve spent months and real money on capsules that did nothing, hear this: that wasn’t you failing. That was you filling a gap nobody else would fill. You were doing your best with what you were offered. Now you can ask for what actually has evidence behind it.
The numbers that prove you were never alone
The guideline also lays out how common this is, and the numbers are worth knowing:
• Between 50% and 92% of women in menopause report hot flushes or night sweats.
• Approximately 16–66% of women in the US report menopause-related sleep disruption.
• Approximately 36% of perimenopausal and postmenopausal women worldwide report depressive symptoms. That’s about one in three.
• Hot flushes can begin more than 10 years before the final period and continue for 10 years or more after.
One more honest note on mood. ACOG says the evidence is not yet strong enough to recommend for or against hormone therapy specifically for menopause-related depression. If you’re dealing with depression, it deserves its own treatment, whatever is happening with your hormones. Low mood that lasts more than a couple of weeks is a reason to talk to your provider, not a reason to tough it out.
How to use the new rulebook at your next appointment
A guideline is only useful if it makes it into the room. Here’s how to bring it.
1. Bring your data
Track your hot flushes, sleep, mood, and energy for a week before the visit. A pattern on paper is much harder to wave away than “I just don’t feel like myself.” Our free 7-Day Symptom Tracker + Doctor Visit Guide is built for exactly this.
2. Name the guideline
You don’t need to be confrontational. Try:
“I read that ACOG just updated its menopause guidance. Can we talk through what it means for me?”
Most clinicians will respect a patient who has done her homework. And if yours hasn’t seen it yet, you’ve just done them a favor.
3. Ask the questions that matter
• “Am I in the window ACOG describes, before 60 or within 10 years of menopause?”
• “Is there anything in my history that makes hormone therapy a bad idea for me?”
• “What are my non-hormonal options if I can’t or don’t want to take hormones?”
• “Would CBT or another non-medication approach help my sleep or mood?”
• “If menopause isn’t your focus, can you refer me to someone who specializes in it?”
4. Know the one safety rule
If you start hormone therapy and have persistent or unexpected bleeding, ACOG says that needs to be checked. Don’t ignore it, and don’t panic about it. Just call.
The goal isn’t to walk out with a prescription. The goal is to walk out with a real conversation, the kind the guideline now says you deserve.
The rules changed. You were right all along.
For a long time, the official message to women in midlife was some version of “it’s natural, you’ll get through it.” Natural, yes. But nobody tells a woman with a broken ankle to just get through it.
The rulebook has caught up with what you were feeling all along. You weren’t being dramatic when you asked for help. You weren’t being difficult when the fan didn’t work. You were asking for care that, it turns out, the experts agree you should have been offered.
So walk in with your tracker, your questions, and your calmest voice.
You don’t have to suffer through it. Your doctor’s own rulebook says so.
— Delaney
Want the full story? Read You’re Not Crazy... You’re Menopausal at notcrazymovement.com/book. And get the free 7-Day Symptom Tracker + Doctor Visit Guide at notcrazymovement.com.
Medical note: This post is educational and is not medical advice. ACOG’s recommendations apply to people without contraindications and are meant to be decided together with a clinician who knows your history. Hormone therapy is not right for everyone. Don’t start or stop any medication without talking to your provider, and seek care promptly for any unexpected bleeding.
-
ACOG’s Clinical Practice Guideline No. 13 (October 15, 2026) strongly recommends hormone therapy for hot flushes and related sleep problems in women without contraindications, ideally started before 60 or within 10 years of menopause. It also strongly recommends non-hormonal options and says soy and herbal supplements aren’t supported.
-
ACOG Clinical Practice Guideline No. 13, “Management of Menopause-Related Vasomotor, Sleep, and Mood Symptoms,” published online October 15, 2026. It replaces ACOG’s January 2014 guidance.
-
Yes. ACOG strongly recommends systemic hormone therapy for hot flushes and related sleep problems in women without contraindications, through shared decision-making with a clinician.
-
ACOG recommends starting it before age 60 or within 10 years of the start of natural menopause. After that, the decision is individualized.
-
ACOG strongly recommends SSRIs or SNRIs and neurokinin receptor antagonists (such as Veozah and Lynkuet) for women who can’t or don’t want hormone therapy, and suggests CBT and other non-drug approaches.
-
ACOG says the available evidence does not support the efficacy or safety of phytoestrogens such as soy isoflavones or herbal supplements, which are not FDA-regulated.
-
Much of the fear came from the Women’s Health Initiative. ACOG notes that nearly 67% of its participants were 60 or older, so the findings are hard to apply to women in their 40s and 50s.
-
In its October 2026 guideline, ACOG uses “hot flush” because the symptom isn’t a momentary flash. A hot flush typically lasts one to five minutes. Both terms describe the same thing: a sudden wave of heat, often with sweating and a flushed face and chest, known medically as a vasomotor symptom (VMS). “Hot flush” is also the term used in much of the world, including the UK.
Sources & References
1. American College of Obstetricians and Gynecologists. Management of menopause-related vasomotor, sleep, and mood symptoms. Clinical Practice Guideline No. 13. Obstetrics & Gynecology. 2026;148(5):e345–e369. Published online October 15, 2026. acog.org
2. American College of Obstetricians and Gynecologists. “ACOG Expands Recommendations for Management of Menopause Symptoms,” news release, October 2026. acog.org
3. US Food and Drug Administration. Labeling changes for menopausal hormone therapy, November 10, 2025 and February 12, 2026. fda.gov
